GFAP and Alzheimer disease: The presence of citrullinated GFAP has also been observed in multiple sclerosis [185, 186], hepatic fibrosis [187], and other neuroinflammatory disorders, raising questions about whether citrullination is a general marker of neuroinflammation or plays a unique role in AD progression.